Transdermal Skin Patches Market Share

Statistics for the 2023 & 2024 Transdermal Skin Patches market share, created by Mordor Intelligence™ Industry Reports. Transdermal Skin Patches share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Transdermal Skin Patches Industry

The transdermal skin patches market is moderately competitive. The key players are focused on adopting product innovations, product launches and approvals, R&D investment for advancements in transdermal patches, and mergers and acquisitions as their developmental strategies to sustain the competitive market environment. Some major companies in the market are Teva Pharmaceuticals USA Inc., Novartis AG, Teikoku Pharma USA Inc., Mylan Inc., and 3M.

Transdermal Skin Patches Market Leaders

  1. Teva Pharmaceuticals USA Inc.

  2. Novartis AG

  3. Teikoku Pharma USA, Inc.

  4. Viatris, Inc.

  5. Johnson & Johnson

*Disclaimer: Major Players sorted in no particular order

Transdermal Skin Patches Market Concentration

Transdermal Skin Patches Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)